Skip to main content

AEON Biopharma, Inc.

For the period ended Dec 31, 2024. Filed Mar 24, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 24, 2025

AEON$0.18-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Marc Forth as such individual’s true and lawful attorney in fact and agent with full power of substitution, for such individual in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney in fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney in fact, proxy and agent, or the individual’s substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

​​​​​
Signature​Title​Date
​​​
/s/ Marc Forth​President, Chief Executive Officer and Director​March 24, 2025
Marc Forth​(Principal Executive and Financial Officer)​
​​​​​
/s/ Jennifer Sy​Vice President, Corporate Controller​March 24, 2025
Jennifer Sy​(Principal Accounting Officer)​​
​​​​​
/s/ Jost Fischer​Chairman of the Board​March 24, 2025
Jost Fischer​​​​
​​​​​
/s/ Shelley Thunen​Director​March 24, 2025
Shelley Thunen​​​​
​​​​​
/s/ Robert Palmisano​Director​March 24, 2025
Robert Palmisano​​​​
​​​​​
/s/ Eric Carter​Director​March 24, 2025
Eric Carter​​​​
​​​​​
/s/ Shawn Park​Director​March 24, 2025
Shawn Park​​​​
​​​​​
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.